Pierre Fabre, Jean-Luc Lowinski
Jean-Luc Lowinski has joined the Pierre Fabre Group as CEO of Pierre Fabre Pharmaceuticals, and he will also sit on the executive committee of the company.
In the role, Lowinski will be responsible for developing the company’s activities in oncology, prescription drugs, and consumer health care.
According to the company, the pharmaceutical division generated €880m ($981m) during 2018.
Prior to joining Pierre Fabre, he spent seven years at Sanofi, where he ended his time as SVP of Sanofi Genzyme emerging markets. He also worked at Bayer for 20 years as the company’s global head of its animal health division.
